Dietary strategies that reduce post-prandial glycemia are important in the prevention and treatment of diabetes and coronary heart disease (CHD). This may be achieved by addition of high-quality protein and fat contained in pistachio nuts, to carbohydrate-containing foods or meals.
A total of 10 healthy volunteers (3 males, 7 females); aged 48.3±6.4 years; Body mass index (BMI) 28.0±4.8 kg/m2 participated in two studies. Study 1 assessed the dose-response effect of 28, 56 and 84 g pistachios consumed alone or co-ingested with white bread (50 g available carbohydrate); Study 2 assessed the effective dose (56 g) of pistachios on post-prandial glycemia consumed with different commonly consumed carbohydrate foods (50 g available carbohydrate). Relative glycemic responses (RGRs) of study meals compared with white bread, were assessed over the 2 h post-prandial period.
The RGRs of pistachios consumed alone expressed as a percentage of white bread (100%) were: 28 g (5.7±1.8%); 56 g (3.8±1.8%); 84 g (9.3±3.2%), P<0.001. Adding pistachios to white bread resulted in a dose-dependent reduction in the RGR of the composite meal; 28 g (89.1±6.0, P=0.100); 56 g (67.3±9.8, P=0.009); 84 g (51.5±7.5, P<0.001). Addition of 56 g pistachios to carbohydrate foods significantly reduced the RGR: parboiled rice (72.5±6.0) versus rice and pistachios (58.7±5.1) (P=0.031); pasta (94.8±11.4) versus pasta and pistachios (56.4±5.0) (P=0.025); whereas for mashed potatoes (109.0±6.6) versus potatoes and pistachios, (87.4±8.0) (P=0.063) the results approached significance.
Pistachios consumed alone had a minimal effect on post-prandial glycemia and when taken with a carbohydrate meal attenuated the RGR. The beneficial effects of pistachios on post-prandial glycemia could, therefore, be part of the mechanism by which nuts reduce the risk of diabetes and CHD.
Post-meal hyperglycemia is an independent risk factor for cardiovascular disease (CVD) (Levitan et al., 2004) and a condition that is common in patients with type 2 diabetes (Akbar, 2003; Bonora et al., 2006). Dietary glycemic index (GI) and glycemic load have been shown to reliably predict the relative post-meal glycemic and insulinemic responses to mixed meals (McMillan-Price et al., 2006; Wolever et al., 2006), and evidence suggests that lowering the GI of a diet can positively affect post-meal plasma glucose excursions (Opperman et al., 2004) and as such, potentially reduce the risk of CVD and diabetes (Salmeron et al., 1997a, 1997b; Liu et al., 2000)
Epidemiological and interventional studies have linked the intake of tree nuts to reduced risk of CVD and diabetes (Jiang et al., 2002; Li et al., 2009; Mente et al., 2009). This protective effect may in part be explained by the favorable impact of nuts on serum lipids (Griel and Kris-Etherton, 2006), oxidative stress (Jenkins et al., 2002) and markers of inflammation (Jiang et al., 2006; Ros, 2009). However, owing to their low available carbohydrate content and favorable fat and protein profiles, nuts may also decrease the risk of CVD and diabetes by reducing post-prandial blood glucose excursions. This mechanism has only been examined in a few clinical studies, which have shown that almonds eaten alone have a minimal effect on blood glucose, and when different doses are consumed with a carbohydrate meal, the post-prandial glucose response is attenuated (Josse et al., 2007).
To further test the potential impact of nuts on post-meal hyperglycemia, we conducted two studies using pistachio nuts. The first assessed the dose-response effect of pistachios on post-prandial blood glucose when consumed alone, and consumed with a white bread meal. The second study assessed the effect of pistachios on post-prandial blood glucose excursions when added to other commonly consumed carbohydrate-rich foods.
Subjects and methods
A total of 10 overweight but otherwise healthy subjects (3 males and 7 females), aged (mean±s.d.) 48.3±6.4 years with a body mass index of 28.0±4.8 kg/m2, were studied. Subjects were not taking any medications that would interfere with glucose metabolism.
Subjects were recruited through local advertisement and through the clinic volunteer roster. Each subject underwent treatments on separate days, performing up to two tests per week with at least one day in between tests. On each test day, subjects came to the research clinic in the morning after a 10–14 h overnight fast. After being weighed and having a fasting blood sample obtained by finger-prick using autolancets (Microlet, Bayer, Toronto, Canada), the subject then consumed a study meal within 10 min, and further finger-prick blood samples were obtained at 15, 30, 45, 60, 90 and 120 min after the start of the meal. Subjects were given a choice of one or two cups of water, tea or coffee with or without milk. The beverage consumed by each subject remained the same for each of their study days. Subjects were instructed not to consume nuts the day before each study day.
The study protocol was approved by the Western Institutional Review Board. Written informed consent was obtained from all subjects before the start of the study.
Meals and palatability
The tests meals in study 1 consisted of three different doses (28, 56 and 84g) of pistachio nuts either consumed alone or together with white bread (50 g available carbohydrate) (Table 1). In study 2, 50 g available carbohydrate portions of rice, pasta or instant mashed potatoes were consumed with or without 56 g of pistachios (Table 1). The control white bread was also consumed on three different occasions to allow calculation of the relative glycemic response (RGR). The control white bread was baked in a bread maker in loaves containing 250 g available carbohydrate. The ingredients for each loaf (250 ml warm water, 340 g all-purpose flour, 7 g sugar, 4 g salt and 6.5 g dry yeast) were placed into the bread maker according to instructions, and the machine was turned on. After the loaf was prepared, it was allowed to cool for an hour, and then weighed and after discarding the crust ends, the remainder was divided into portion sizes containing 50 g available carbohydrate. These portions were frozen before use, and reheated in a microwave before consumption. Study meals were given in random order.
Palatability was rated on a 100 mm visual analog scale anchored with ‘very unpalatable’ at one end and ‘very palatable’ at the other. The higher the number, the higher was the perceived palatability of the product.
Blood glucose analysis
Blood samples were stored at −20 °C until analysis, which took place within 4 days of collection. Blood glucose was analyzed using a Yellow Springs Instrument Model 2300 STAT (Yellow Springs, OH, USA).
Incremental areas under the plasma glucose curves were calculated using the trapezoid rule, ignoring area beneath the baseline value. The GI or RGR was calculated by expressing each subject's glucose incremental areas under the plasma glucose curves for the test food as a percentage of the same subject's average response after consuming the reference white bread. The mean of the resulting values was the RGR. To calculate the RGR, based on the glucose scale (that is, GI of glucose=100), the RGR bread scale values were multiplied by 0.71. The blood glucose concentrations at each time point and the incremental areas under the plasma glucose curve values were subjected to repeated-measures analysis of variance, examining for the effect of test meal. After demonstration of significant heterogeneity, the significance of the differences between individual means was assessed using Tukey's test to adjust for multiple comparisons. In addition, the significance of the differences between blood glucose concentrations and increments for each test food and white bread were assessed by paired t-test. To estimate the RGR lowering potential of 1 g of pistachios, the change in RGR for each study meal was averaged and calculated per gram of pistachio consumed.
Relative glycemic response
Mean fasting blood glucose was identical before each test meal within each series. The glycemic response to all three doses of pistachios was significantly lower at 30, 45, 60 and 90 min after ingestion in comparison with the white bread control (P<0.01) (Figure 1a). Furthermore, 28, 56 and 84 g of pistachios had significantly lower RGR in comparison with white bread (5.7±1.8, 3.8±1.8 and 9.3±3.2 versus 100, respectively; P<0.001) (Table 2). Similarly, adding increasing doses of pistachios to white bread significantly reduced the glycemic response at 30, 45, 60 and 90 min for the 84 g dose (P<0.01), at 45, 60 and 90 min for the 56 g dose (P<0.01) and at 45 and 60 min for the 28 g dose (P<0.01) in comparison with the white bread control (Figure 1b). When pistachio nuts were added to the white bread meal, only the higher doses, 56 and 84 g, resulted in significant reductions in the RGR in comparison with the white bread control (67.3±9.8 (P=0.009) and 51.5±7.5 (P<0.001) versus 100, respectively) (Table 2).
In study 2, the addition of 56 g of pistachios to other commonly consumed carbohydrate rich foods (parboiled rice, pasta and potatoes) resulted in reduced glycemic responses (Table 3). When the pistachio meals were compared with their respective control meals, the addition of 56 g of pistachios significantly lowered the RGR of both parboiled rice (72.5±6.0 versus 58.7±5.1; P=0.031) and pasta (94.8±11.4 versus 56.4±5.0; P=0.025), whereas the reduction approached significance for instant mashed potatoes (109.0±6.6 versus 87.4±8.0; P=0.063) (Table 3; Figure 2). The mean reduction in glycemic response observed per gram of pistachios consumed was found to be 0.35 U, that is, 1 g of pistachios added to a food lowered the RGR of that food by 0.35 units on the glucose scale or 0.49 U on the bread scale. It must be pointed out that these results may only apply to the foods tested and results may be different for foods varying in composition and physical form (for example, beverages).
The present study is the first to assess the effect of pistachio nuts on post-prandial glycemia. The findings confirm the very low glycemic responses to pistachios eaten alone would be predicted on the basis of their low available carbohydrate content (6 g per ounce) and on the results of other nuts (almonds) and oil seeds (peanuts), (Johnston and Buller, 2005; Jenkins et al., 2006; Josse et al., 2007). Moreover, these data demonstrate that the addition of pistachios to foods with high available carbohydrate content reduces the overall glycemic impact of the foods studied (parboiled rice, pasta, white bread and mashed potatoes), despite increasing the overall available carbohydrate content. Of particular interest was the progressive reduction in bread glycemic response with the increasing doses of pistachios. The graded glycemic response reduction of white bread has also been observed with almonds in a similar dose-response study conducted in healthy individuals (Josse et al., 2007). Pistachios and other nuts are energy-dense foods, and it has been recognized that gastric emptying is reduced by a high fat and energy load such that the pylorus tends to regulate the flow of energy into the duodenum (Hunt and Stubbs, 1975; Peracchi et al., 2000). A study by Henry et al. (2008) found that the glycemic response of bread can be lowered by the addition of any type of fat. Thus, increasing energy and fat load with an increasing dose of pistachios would therefore tend to reduce the glycemic response in a dose-dependent manner as observed. It is also possible that the addition of pistachios resulted in a reduction in carbohydrate absorption or altered the osmotic load and volume of the stomach, all of which would alter the post-prandial glycemic response. The acute benefits of pistachios on glycemia observed in the current study may be indicative of long-term improvements in glycemic control in light of recent evidence showing that the addition of 60–100 g of pistachios to a Mediterranean diet for 4 weeks significantly reduced fasting glucose levels in healthy adults in comparison with an unmodified Mediterranean diet (Sari et al., 2010).
The low post-meal glycemic response to pistachios is also of particular interest in relation to recent studies, indicating that nut consumption was protective for CVD (Fraser et al., 1992; Hu et al., 1998; Ellsworth et al., 2001; Kris-Etherton et al., 2001; Albert et al., 2002). In each of these large prospective studies, the Physicians’ Health Study (Albert et al., 2002), the Iowa Women's Health Study (Ellsworth et al., 2001), the Nurses’ Health Study (Hu et al., 1998) and the Adventist Health Study (Fraser et al., 1992), those who consumed the greatest amount of nuts versus those who consumed the least had significant reductions in the risk of death from CVD, relative risk=0.53, 0.81, 0.65 and 0.52, respectively. Clinically, post-meal hyperglycemia has been linked to endothelial dysfunction (Williams et al., 1998; Kawano et al., 1999) and oxidative stress (Ceriello et al., 2004); both of which are CVD risk factors. Post-prandial lipemia has also been associated with an increased risk for coronary heart disease (CHD). Although consumption of nuts would increase post-prandial lipemia, a study by Berry et al. (2008) found that eating whole almonds resulted in a lower post-prandial rise in plasma triglycerides compared with almond oil or sunflower oil meals (74 and 58%, respectively) that were balanced for macronutrients and fiber. In addition, nuts have a healthy fatty acid profile that is largely unsaturated and may provide other CHD benefits beyond reducing the post-prandial glycemic impact of a meal. Monounsaturated fat tends to raise high-density lipoprotein cholesterol when exchanged for carbohydrate, and the Mensink and Katan equation also attribute a small but important low-density lipoprotein cholesterol lowering effect to monounsaturated fat (Mensink and Katan, 1992). This lowering of low-density lipoprotein cholesterol is supported by a number of studies, which have shown that pistachios (Edwards et al., 1999; Kocyigit et al., 2006; Sheridan et al., 2007; Gebauer et al., 2008; Kay et al., 2010; Sari et al., 2010), almonds (Griel and Kris-Etherton, 2006) and walnuts (Banel and Hu, 2009) can potentially reduce the risk of CVD by improving serum lipid concentrations.
The low glycemic effect of nuts may provide a reason for the inclusion of nuts in diets aimed at reducing the risk of diabetes as the substitution of nuts for high GI carbohydrates would reduce the glycemic load of the diet. Furthermore, it may be beneficial to advise people with Type 2 diabetes to consume nuts when they consume carbohydrates as part of their daily diet to reduce the acute, post-prandial glycemic impact of the meal. These recommendations are supported by recent recommendations by both the American Diabetes Association and the International Diabetes Federation, which emphasize management of post-meal hyperglycemia as an important component in the management and prevention of Type 2 diabetes (American Diabetes Association (ADA), 2007; International Diabetes Federation, 2007).
Few studies have assessed the effect of nuts on diabetes risk and control. Of the two cohort studies, only the results from the Nurses Health Study cohort (Jiang et al., 2002) but not the Iowa Women's Health Study (Parker et al., 2003) indicate that consumption of five or more servings per week of nuts compared with rarely or no intake reduces the risk of developing diabetes (relative risk=0.73, 95% confidence interval, 0.60–0.89). Data from clinical studies indicate that nuts are beneficial in reducing CHD lipid risk factors in patients with diabetes or the metabolic syndrome (Lovejoy et al., 2002; Tapsell et al., 2004; Estruch et al., 2006; Li et al., 2009). In addition, some studies have found a significant reduction in fasting insulin (Casas-Agustench et al., 2011; Tapsell et al. 2009) or a significant improvement in insulin resistance (Casas-Agustench et al., 2011). However, none have reported a significant reduction in glycated proteins as a marker of long-term glycemic control (Lovejoy et al., 2002; Scott et al., 2003; Tapsell et al., 2004; Estruch et al., 2006; Mukuddem-Petersen et al., 2007; Casas-Agustench et al., 2011; Tapsell et al., 2009; Ma et al., 2010). In light of recent evidence showing that the combination of the 2 h post-meal glucose levels and fasting blood glucose allow for better estimation of risk both for diabetes and CVD than the fasting blood glucose alone (Sorkin et al., 2005; International Diabetes Federation, 2007); further studies that examine the effect of nuts on post-meal glycemia are warranted.
We conclude that pistachios resulted in a minimal rise in blood glucose when fed alone over a wide range of acceptable intake levels. Moreover, they also depress the blood glucose response to bread in a dose-dependent manner and the glycemic response of other carbohydrate rich meals, possibly related to their high fat, fiber and protein content. In view of their favorable fatty acid profile, their beneficial effects on serum lipid levels and their low glycemic impact, it seems now appropriate to assess their effects in longer-term studies of diabetes. These studies should aim at reducing the dietary glycemic load to assess whether nut consumption results in reduced concentrations of long-term biomarkers of glycemic control, such as glycated proteins. However, it is important to note that in the context of a healthy diet, care must be taken not to increase calories above requirement and nuts should be substituted for other foods and not simply added to one's diet.
Akbar DH (2003). Sub-optimal postprandial blood glucose level in diabetics attending the outpatient clinic of a University Hospital. Saudi Med J 24, 1109–1112.
Albert CM, Gaziano JM, Willett WC, Manson JE (2002). Nut consumption and decreased risk of sudden cardiac death in the Physician's Health Study. Arch Intern Med 162, 1382–1387.
American Diabetes Association (ADA) (2007). Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 30 (Suppl 1), S48–S65.
Atkinson FS, Foster-Powell K, Brand-Miller JC (2008). International tables of glycemic index and glycemic load values: 2008. Diabetes Care 31, 2281–2283.
Banel DK, Hu FB (2009). Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. Am J Clin Nutr 90, 56–63.
Berry SE, Tydeman EA, Lewis HB, Phalora R, Rosborough J, Picout DR et al. (2008). Manipulation of lipid bioaccessibility of almond seeds influences postprandial lipemia in healthy human subjects. Am J Clin Nutr 88, 922–929.
Bonora E, Corrao G, Bagnardi V, Ceriello A, Comaschi M, Montanari P et al. (2006). Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus. Diabetologia 49, 846–854.
Casas-Agustench P, Lopez-Uriarte P, Bullo M, Ros E, Cabre-Vila JJ, Salas-Salvado J (2011). Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis 21, 126–135.
Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A et al. (2004). Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53, 701–710.
Edwards K, Kwaw I, Matud J, Kurtz I (1999). Effect of pistachio nuts on serum lipid levels in patients with moderate hypercholesterolemia. J Am Coll Nutr 18, 229–232.
Ellsworth JL, Kushi LH, Folsom AR (2001). Frequent nut intake and risk of death from coronary heart disease and all causes in postmenopausal women: the Iowa Women's Health Study. Nutr Metab Cardiovasc Dis 11, 372–377.
Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI et al. (2006). Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 145, 1–11.
Fraser GE, Sabate J, Beeson WL, Strahan TM (1992). A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch Intern Med 152, 1416–1424.
Gebauer SK, West SG, Kay CD, Alaupovic P, Bagshaw D, Kris-Etherton PM (2008). Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study. Am J Clin Nutr 88, 651–659.
Griel AE, Kris-Etherton PM (2006). Tree nuts and the lipid profile: a review of clinical studies. Br J Nutr 96 (Suppl 2), S68–S78.
Henry CJ, Lightowler HJ, Newens KJ, Pata N (2008). The influence of adding fats of varying saturation on the glycaemic response of white bread. Int J Food Sci Nutr 59, 61–69.
Hu FB, Stampfer MJ, Manson JE, Rimm EB, Colditz GA, Rosner BA et al. (1998). Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ 317, 1341–1345.
Hunt JN, Stubbs DF (1975). The volume and energy content of meals as determinants of gastric emptying. J Physiol 245, 209–225.
International Diabetes Federation (2007). Guideline for Management of Postmeal Glucose. International Diabetes Federation: Brussels, Belgium.
Jenkins DJ, Kendall CW, Josse AR, Salvatore S, Brighenti F, Augustin LS et al. (2006). Almonds decrease postprandial glycemia, insulinemia, and oxidative damage in healthy individuals. J Nutr 136, 2987–2992.
Jenkins DJ, Kendall CW, Marchie A, Parker TL, Connelly PW, Qian W et al. (2002). Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation 106, 1327–1332.
Jiang R, Jacobs Jr DR, Mayer-Davis E, Szklo M, Herrington D, Jenny NS et al. (2006). Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. Am J Epidemiol 163, 222–231.
Jiang R, Manson JE, Stampfer MJ, Liu S, Willett WC, Hu FB (2002). Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA 288, 2554–2560.
Johnston CS, Buller AJ (2005). Vinegar and peanut products as complementary foods to reduce postprandial glycemia. J Am Diet Assoc 105, 1939–1942.
Josse AR, Kendall CW, Augustin LS, Ellis PR, Jenkins DJ (2007). Almonds and postprandial glycemia—a dose-response study. Metabolism 56, 400–404.
Kay CD, Gebauer SK, West SG, Kris-Etherton PM (2010). Pistachios increase serum antioxidants and lower serum oxidized-LDL in hypercholesterolemic adults. J Nutr 140, 1093–1098.
Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T et al. (1999). Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34, 146–154.
Kocyigit A, Koylu AA, Keles H (2006). Effects of pistachio nuts consumption on plasma lipid profile and oxidative status in healthy volunteers. Nutr Metab Cardiovasc Dis 16, 202–209.
Kris-Etherton PM, Zhao G, Binkoski AE, Coval SM, Etherton TD (2001). The effects of nuts on coronary heart disease risk. Nutr Rev 59, 103–111.
Levitan EB, Song Y, Ford ES, Liu S (2004). Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164, 2147–2155.
Li TY, Brennan AM, Wedick NM, Mantzoros C, Rifai N, Hu FB (2009). Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. J Nutr 139, 1333–1338.
Liu S, Willett WC, Stampfer MJ, Hu FB, Franz M, Sampson L et al. (2000). A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 71, 1455–1461.
Lovejoy JC, Most MM, Lefevre M, Greenway FL, Rood JC (2002). Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am J Clin Nutr 76, 1000–1006.
Ma Y, Njike VY, Millet J, Dutta S, Doughty K, Treu JA et al. (2010). Effects of walnut consumption on endothelial function in type 2 diabetic subjects: a randomized controlled crossover trial. Diabetes Care 33, 227–232.
McMillan-Price J, Petocz P, Atkinson F, O’Neill K, Samman S, Steinbeck K et al. (2006). Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial. Arch Intern Med 166, 1466–1475.
Mensink RP, Katan MB (1992). Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 12, 911–919.
Mente A, de Koning L, Shannon HS, Anand SS (2009). A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 169, 659–669.
Mukuddem-Petersen J, Stonehouse Oosthuizen W, Jerling JC, Hanekom SM, White Z (2007). Effects of a high walnut and high cashew nut diet on selected markers of the metabolic syndrome: a controlled feeding trial. Br J Nutr 97, 1144–1153.
Opperman AM, Venter CS, Oosthuizen W, Thompson RL, Vorster HH (2004). Meta-analysis of the health effects of using the glycaemic index in meal planning. Br J Nutr 92, 367–381.
Parker ED, Harnack LJ, Folsom AR (2003). Nut consumption and risk of type 2 diabetes. JAMA 290, 38–39;author reply 39–40.
Peracchi M, Gebbia C, Ogliari C, Fraquelli M, Vigano R, Baldassarri A et al. (2000). Influence of caloric intake on gastric emptying of solids assessed by 13C-octanoic acid breath test. Scand J Gastroenterol 35, 814–818.
Ros E (2009). Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr 89, 1649S–1656S.
Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ et al. (1997a). Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20, 545–550.
Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC (1997b). Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277, 472–477.
Sari I, Baltaci Y, Bagci C, Davutoglu V, Erel O, Celik H et al. (2010). Effect of pistachio diet on lipid parameters, endothelial function, inflammation, and oxidative status: a prospective study. Nutrition 26, 399–404.
Scott LW, Balasubramanyam A, Kimball KT, Aherns AK, Fordis Jr CM, Ballantyne CM (2003). Long-term, randomized clinical trial of two diets in the metabolic syndrome and type 2 diabetes. Diabetes Care 26, 2481–2482.
Sheridan MJ, Cooper JN, Erario M, Cheifetz CE (2007). Pistachio nut consumption and serum lipid levels. J Am Coll Nutr 26, 141–148.
Sorkin JD, Muller DC, Fleg JL, Andres R (2005). The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28, 2626–2632.
Tapsell LC, Batterham MJ, Teuss G, Tan SY, Dalton S, Quick CJ et al. (2009). Long-term effects of increased dietary polyunsaturated fat from walnuts on metabolic parameters in type II diabetes. Eur J Clin Nutr 63, 1008–1015.
Tapsell LC, Gillen LJ, Patch CS, Batterham M, Owen A, Bare M et al. (2004). Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 27, 2777–2783.
Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC et al. (1998). Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97, 1695–1701.
Wolever TM, Yang M, Zeng XY, Atkinson F, Brand-Miller JC (2006). Food glycemic index, as given in glycemic index tables, is a significant determinant of glycemic responses elicited by composite breakfast meals. Am J Clin Nutr 83, 1306–1312.
We are grateful to the Western Pistachio Association, Fresno, CA, USA for provision of the pistachios and for funding for additional statistics. This work was supported by the Western Pistachio Association, Fresno, CA, USA and the California Pistachio Commission. DJAJ is funded by the Federal Government of Canada as a Canada Research Chair in Nutrition and Metabolism.
David Jenkins has served on the Scientific Advisory Board of Loblaw Brands Ltd, Sanitarium, Herbalife International, Nutritional Fundamentals for Health, Pacific Health Laboratories, Metagenics/MetaProteomics, Bayer Consumer Care, Almond Board of California, California Strawberry Commission, Orafti, Unilever and Solae. Cyril Kendall has served on the Scientific Advisory Board of Paramount Farms. David Jenkins and Cyril Kendall have received grants from Barilla, Solae, Unilever, Hain Celestial, Loblaw Brands, Sanitarium, Almond Board of California, International Tree Nut Council, California Strawberry Commission, the Western Pistachio Association, Orafti, and the Canola and Flax Councils of Canada. David Jenkins has been on the speakers’ panel for the Almond Board of California. Cyril Kendall has been on the speakers’ panel for the Almond Board of California, Paramount Farms and the International Tree Nut Council.
About this article
Cite this article
Kendall, C., Josse, A., Esfahani, A. et al. The impact of pistachio intake alone or in combination with high-carbohydrate foods on post-prandial glycemia. Eur J Clin Nutr 65, 696–702 (2011). https://doi.org/10.1038/ejcn.2011.12
- glycemic index
- glycemic load
Acute Effect of Pistachio Intake on Postprandial Glycemic and Gut Hormone Responses in Women With Gestational Diabetes or Gestational Impaired Glucose Tolerance: A Randomized, Controlled, Crossover Study
Frontiers in Nutrition (2019)
The effect of nuts on markers of glycemic control: a systematic review and meta-analysis of randomized controlled trials
The American Journal of Clinical Nutrition (2019)
Effect of pistachio on brachial artery diameter and flow-mediated dilatation: A systematic review and meta-analysis of randomized, controlled-feeding clinical studies
Critical Reviews in Food Science and Nutrition (2019)
The Postprandial Appearance of Features of Cardiometabolic Risk: Acute Induction and Prevention by Nutrients and Other Dietary Substances
Nutrition & Diabetes (2018)